ABT:NYE-Abbott Laboratories (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 131.3

Change

0.00 (0.00)%

Market Cap

USD 56.45B

Volume

6.15M

Analyst Target

USD 115.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
MDT Medtronic PLC

+0.50 (+0.62%)

USD 110.86B
STE STERIS plc

+3.20 (+1.32%)

USD 22.11B
ZBH Zimmer Biomet Holdings Inc

+1.57 (+1.69%)

USD 20.08B
SNN Smith & Nephew SNATS Inc

+0.29 (+1.01%)

USD 12.64B
PEN Penumbra Inc

+4.09 (+1.52%)

USD 10.40B
GMED Globus Medical

+0.63 (+1.07%)

USD 7.98B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 7.14B
BIO Bio-Rad Laboratories Inc

+6.58 (+2.94%)

USD 6.69B
GKOS Glaukos Corp

+0.95 (+0.99%)

USD 5.49B
INSP Inspire Medical Systems Inc

-0.06 (-0.04%)

USD 4.50B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 16.05 % 0.00 %

N/A

N/A
EDOC:AU 7.78 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 5.49 % 0.00 %

+0.39 (+1.36%)

USD 0.02B
HART IQ Healthy Hearts ETF 5.31 % 0.00 %

+0.45 (+1.36%)

USD 8.84M
LIFE-U:CA Evolve Global Healthcare .. 5.05 % 0.00 %

+0.17 (+1.36%)

N/A
XLV Health Care Select Sector.. 4.79 % 0.13 %

+1.82 (+1.36%)

USD 33.98B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.68 % 0.00 %

+0.25 (+1.36%)

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.61 % 0.00 %

+0.24 (+1.36%)

N/A
CWS AdvisorShares Focused Equ.. 4.52 % 0.68 %

+0.87 (+1.36%)

USD 0.18B
SXLV:SW SPDR S&P U.S. Health Care.. 4.44 % 0.00 %

N/A

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 4.42 % 0.00 %

+0.56 (+1.36%)

USD 0.40B
XGES:LSE Xtrackers MSCI Genomic He.. 4.35 % 0.00 %

+0.35 (+1.36%)

N/A
XUHC:F Xtrackers (IE) Public Lim.. 4.28 % 0.00 %

+0.52 (+1.36%)

USD 0.85B
QLTY The 2023 ETF Series Trust.. 4.20 % 0.00 %

+0.65 (+1.36%)

USD 1.82B
FHLC Fidelity® MSCI Health Ca.. 4.14 % 0.08 %

+0.86 (+1.36%)

USD 2.37B
SAMM The Advisors’ Inner .. 3.91 % 0.00 %

+0.37 (+1.36%)

USD 0.02B
BMED BlackRock Future Health E.. 3.78 % 0.00 %

+0.26 (+1.36%)

USD 2.84M
DRUG:AU BetaShares Global Healthc.. 3.77 % 0.00 %

N/A

USD 0.17B
CURE Direxion Daily Healthcare.. 3.64 % 1.06 %

+3.07 (+1.36%)

USD 0.12B
IUAE:CA Invesco S&P US Dividend A.. 3.56 % 0.00 %

+0.24 (+1.36%)

CAD 1.21M
WELG:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

+0.06 (+1.36%)

N/A
WELS:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

+0.07 (+1.36%)

N/A
XUHC:SW 3.38 % 0.00 %

N/A

N/A
FOHW:XETRA Franklin Future of Health.. 3.37 % 0.00 %

+0.18 (+1.36%)

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.36 % 0.00 %

+0.01 (+1.36%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.36 % 0.00 %

+42.75 (+1.36%)

N/A
SPMV Invesco S&P 500 Minimum V.. 3.12 % 0.00 %

+0.70 (+1.36%)

USD 5.48M
XDWH:F Xtrackers (IE) Public Lim.. 3.05 % 0.00 %

+0.50 (+1.36%)

USD 2.60B
XWHS:LSE Xtrackers MSCI World Heal.. 3.05 % 0.00 %

+40.75 (+1.36%)

USD 2.72B
WHEA:SW SPDR MSCI World Health Ca.. 3.05 % 0.00 %

+0.06 (+1.36%)

N/A
SPLV:SW iShares Edge S&P 500 Mini.. 3.01 % 0.00 %

+1.14 (+1.36%)

USD 1.23B
HEAL:CA 2.82 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.36 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.29 % 0.00 %

+0.09 (+1.36%)

N/A
MFSV MFS Active Value ETF 2.27 % 0.00 %

+0.33 (+1.36%)

N/A
2B78:XETRA iShares Healthcare Innova.. 2.06 % 0.00 %

+0.05 (+1.36%)

USD 1.05B
CGCV Capital Group Conservativ.. 2.02 % 0.00 %

+0.42 (+1.36%)

USD 0.35B
HEAL:SW iShares Healthcare Innova.. 2.01 % 0.00 %

+0.02 (+1.36%)

USD 1.05B
HYLG 1.58 % 0.00 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.47 % 0.39 %

+0.40 (+1.36%)

CAD 0.21B
ZHU:CA BMO Equal Weight US Healt.. 1.47 % 0.00 %

+0.95 (+1.36%)

CAD 0.01B
IUSD:XETRA iShares MSCI World Islami.. 1.46 % 0.00 %

+0.42 (+1.36%)

N/A
ISWD:SW iShares MSCI World Islami.. 1.45 % 0.00 %

+0.89 (+1.36%)

USD 0.65B
XDEW:SW 0.25 % 0.00 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.81 (+1.36%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.81 (+1.36%)

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

+0.55 (+1.36%)

USD 5.50B
VALQ American Century STOXX U... 0.00 % 0.29 %

+0.92 (+1.36%)

USD 0.25B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.11 (+1.36%)

CAD 0.10B
DVOL First Trust Dorsey Wright.. 0.00 % 0.60 %

+0.32 (+1.36%)

USD 0.07B
RWDC 0.00 % 0.00 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.36 (1.36%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.36 (1.36%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+1.03 (+1.36%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+3.39 (+1.36%)

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.85 (+1.36%)

CAD 0.56B
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.89 %

+0.24 (+1.36%)

CAD 0.02B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+10.88 (+1.36%)

N/A
ISDU:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

+1.46 (+1.36%)

USD 0.22B
ISDW:LSE iShares MSCI World Islami.. 0.00 % 0.00 %

+0.83 (+1.36%)

USD 0.65B
ISUS:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

+99.50 (+1.36%)

USD 0.22B
ISWD:LSE iShares MSCI World Islami.. 0.00 % 0.00 %

+64.50 (+1.36%)

USD 0.65B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.15 (+1.36%)

USD 2.40B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.61 (+1.36%)

N/A
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

+0.31 (+1.36%)

N/A
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

+11.75 (+1.36%)

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+56.50 (+1.36%)

USD 0.65B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.83 (+1.36%)

USD 0.65B
DXSB:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-0.26 (1.36%)

N/A
DXSB:XETRA Xtrackers - Stoxx Global .. 0.00 % 0.00 %

-0.62 (1.36%)

USD 0.68B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.06 (+1.36%)

N/A
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.20 (+1.36%)

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.41 (+1.36%)

N/A
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.25 (+1.36%)

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+1.03 (+1.36%)

USD 1.47B
ANEW ProShares MSCI Transforma.. 0.00 % 0.00 %

+0.70 (+1.36%)

USD 8.15M
FUD-A:CA 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.08 (+1.36%)

CAD 0.08B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

+0.12 (+1.36%)

N/A
MFUT MFUT 0.00 % 0.00 %

-0.04 (1.36%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.08% 88% B+ 90% A-
Dividend Return 1.04% 60% D- 42% F
Total Return 17.12% 91% A- 91% A-
Trailing 12 Months  
Capital Gain 26.31% 88% B+ 90% A-
Dividend Return 2.19% 63% D 43% F
Total Return 28.50% 88% B+ 90% A-
Trailing 5 Years  
Capital Gain 44.67% 71% C- 58% F
Dividend Return 10.82% 88% B+ 28% F
Total Return 55.49% 75% C 52% F
Average Annual (5 Year Horizon)  
Capital Gain 0.62% 52% F 40% F
Dividend Return 2.08% 52% F 35% F
Total Return 1.45% 75% C 35% F
Risk Return Profile  
Volatility (Standard Deviation) 17.04% 88% B+ 57% F
Risk Adjusted Return 12.19% 58% F 32% F
Market Capitalization 56.45B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.70 79% 48%
Price/Book Ratio 4.80 30% 19%
Price / Cash Flow Ratio 27.40 14% 10%
Price/Free Cash Flow Ratio 21.76 21% 14%
Management Effectiveness  
Return on Equity 30.65% 100% 93%
Return on Invested Capital 22.97% 89% 91%
Return on Assets 6.38% 96% 83%
Debt to Equity Ratio 26.49% 53% 75%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector